Competitive and Technical Intelligence ToolBox

The PCT Time Limit Calculator assists applicants in the computing of essential PCT Time Limits. 1. Main Time Limits : To calculate the time limits for submission of priority document, international publication and entry into the national/regional phase, please enter the earliest priority date. 2. Correct / Add Priority : To calculate the time limit for correcting or adding a priority claim, please enter the earliest priority date, the priority date as proposed to be changed and the international filing date. 3. Amended Claims : To calculate the time limit for Article 19 amendments, please enter the earliest priority date and the ISR transmittal date. Demand: To calculate the time limit for making a demand for international preliminary examination, please enter the earliest priority date and the ISR transmittal date. 4. Withdrawal : To calculate the time limit for withdrawal, please enter the earliest priority date. 5. Record Change : To calculate the time limit for recording changes,

Indian Patent searching is now easy, see the following two interface to search Indian patents. 1. Patent Search : 18 Months Publication Link - https://www.ipindiaonline.gov.in/patentpublishedSearch/patentwebSearch.aspx 2. Public Search for Patents Link - http://www.ipindia.nic.in/patsea.htm

Different products enter the market everyday. A consumer chooses a particular product based on certain conditions. An understanding of these conditions gives you an edge over your competitors. Competitor Analysis Services provide a thorough knowledge of who your competitors are their marketing strategies, objectives, their strengths and weaknesses. Competitor Analysis help a company understand its position with respect to its major competitors in the competitive market and provide business competitive intelligence and to understand the key competitors’ strategies and so to provide a proactive, planned and informed approach to its own strategies in order to gain an upper hand. Cheers Interactive (India) Pvt. Ltd , Navi Mumbai, India provide consistence business competitive intelligence services, enabling their clients in making profitable strategic business decisions.

By: iStockAnalyst Tuesday, July 01, 2008 4:29 AM LONDON -(Dow Jones)- Oxford BioMedica (LSE:OXB) , a gene therapy company, Tuesday announced that it has been informed that Bavarian Nordic filed a patent infringement action against Oxford BioMedica (LSE:OXB) , BioMedica Inc. and Oxford BioMedica (LSE:OXB) (U.K.) in the United States District Court for the Southern District of California. These patents correspond to Bavarian Nordic's European Patent No. 1335987, which is the subject of multiple oppositions, all asserting the invalidity of the claimed technology. Bavarian Nordic's claim is that the MVA vector system employed in Oxford BioMedica's (LSE:OXB) therapeutic cancer vaccine, TroVax, which is in clinical development, infringes these U.S. patents. Full article

July 02, 2008: 01:08 PM EST SAN JOSE, Calif., July 2 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, announced today that it has asserted patent infringement claims in the United States District Court, Northern District of California, against biolitec Inc. (Biolitec), Dornier MedTech America, Inc. (Dornier) and NewStar Lasers, Inc. d/b/a CoolTouch, Inc. (CoolTouch). Biolitec, CoolTouch and Dornier market endovenous laser ablation products for use in procedures which VNUS believes infringe several of its patents. VNUS is seeking an injunction prohibiting these companies from selling these products, in addition to monetary damages. The new lawsuit involves patents that VNUS previously asserted in 2005 against Diomed Holdings, Inc., AngioDynamics, Inc. and Vascular Solutions, Inc. VNUS entered into an agreement on June 3, 2008 with AngioDynamics and Vascular So

AstraZeneca announced on 1st July 2008, that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as a result of Teva's and Sandoz's filings of Abbreviated New Drug Applications (ANDAs). Read full article

Cheers Interactive (I) Pvt. Ltd. has an opening for Manager in patent research and analytic in Electronic domain. Suitable electronic engineering having proven track records, excellent technical understanding and able to handle other domains with 3+ years of experience in patent search and analytics, contact to Mr. Ravi (ravi.panjwani@cheersin.com) immediately with latest resume.